Cargando…
Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis
Peritoneal carcinomatosis (PC) from gastric cancer has traditionally been considered a terminal progression of the disease and is associated with poor survival outcomes. Positive peritoneal cytology similarly worsens the survival of patients with gastric cancer and treatment options for these patien...
Autores principales: | Leiting, Jennifer L, Grotz, Travis E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198298/ https://www.ncbi.nlm.nih.gov/pubmed/30364780 http://dx.doi.org/10.4251/wjgo.v10.i10.282 |
Ejemplares similares
-
Advancements and challenges in treating advanced gastric cancer in the West
por: Leiting, Jennifer L, et al.
Publicado: (2019) -
Gastric Cancer Peritoneal Carcinomatosis Risk Score
por: Ji, Liang, et al.
Publicado: (2019) -
Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis
por: Lee, Ting-Ying, et al.
Publicado: (2021) -
Surgical Treatment of Peritoneal Carcinomatosis from Gastric Cancer
por: Turaga, Kiran K., et al.
Publicado: (2012) -
RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis
por: Kim, Hee Kyung, et al.
Publicado: (2019)